Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-13

Clinical Trial Update: Effects of Oxytocin Nasal Spray on Social Affiliation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxytocin nasal spray for social affiliation in schizophrenia has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin nasal spray (oxytocin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2018-12-13